 CAMBRIDGE, Mass.BUSINESS WIREUniversal Diagnostics Universal DX, a bioinformatics and multi-omics company on a mission to transform cancer into a curable disease, today announced the results of an international, observational cohort study which evaluated the effectiveness of utilizing a combination of cell-free DNA cfDNA methylation, fragmentation and machine learning to detect early-stage colorectal cancer CRC. This ... New Data from Universal DX Demonstrates Effective Detection of... 